This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Photo: Christophe Gateau/dpa (Photo by Christophe Gateau/picture alliance via Getty Images) ...

The median overall survival was 13.1 months in patients with RAS G12 mutations. Current PDAC therapies provide only modest benefit, study researchers noted. Because activating RAS mutations occur in ...

This is a syndicated post stub. Clinical Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical ...

After dropping headline-grabbing phase 3 data for its pancreatic cancer candidate daraxonrasib last week, Revolution Medicines is not resting on its laurels. The Bay Area biotech has spent several ...

Every year, the NFL scouting combine allows for college football prospects to interview with NFL teams one-on-one for the first time. Franchises also use the time to get medical checkups for each ...

Determining the recipe for successful work teams is big business, as a lot is at stake. Is the key having the right set of members based on their skills or personalities? Is the primary driver of team ...

Spinal deformities such as scoliosis and kyphosis are among the most serious complications of neurofibromatosis type 1 (NF1), a genetic disorder that affects about one in 3,000 people. These ...

If you feel a lift after exercise, you're in good company. Movement can boost mood, and according to the results of a new study, it can also help relieve symptoms of depression. As part of a review of ...

Flu is surging across most of the U.S. But, amid an early, harsh season, there is a glimmer of promising news: The flu shot may be more effective than experts predicted. Subscribe to read this story ...